CALVIN PARKER: Open Payments
NPI 1174116438 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 28 payments from 9 companies in 2025. Trend: 2023 $170 · 2024 $71 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $203 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Lilly USA, LLC | 4 | $66 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| ABBVIE INC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: REXULTI, Wegovy, Rybelsus, SHINGRIX, MOUNJARO, QULIPTA, Ozempic, UBRELVY.
Industry payments across NC — which companies pay providers there.
